Cystic fibrosis and rare pulmonary disorders require specialized diagnostic and therapeutic approaches. This session will focus on recent advances in understanding the molecular mechanisms underlying these diseases. Researchers will discuss innovative treatment strategies and emerging therapeutic targets. Advances in personalized medicine for rare lung disorders will be highlighted.
Presentations will examine genetic testing, disease monitoring, and novel pharmacological interventions. Participants will gain insights into multidisciplinary management approaches and long-term patient care. Clinical research findings and case studies will also be presented. Emerging therapies aimed at improving quality of life will be discussed.
The session will address challenges associated with early diagnosis, access to treatment, and healthcare disparities. Experts will discuss future opportunities in rare lung disease research. International collaborations aimed at improving patient outcomes will be encouraged. This session aims to advance comprehensive care for rare respiratory diseases.